Orthofix International (OFIX) Misses Q4 EPS by 7c, Revenues Miss; Offers Q1 & FY20 EPS/Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Orthofix Reports Fourth Quarter and Fiscal Year 2019 Financial Results
February 24, 2020 4:03 PM ESTFourth Quarter Highlights
Net sales of $121.5 million, an increase of 0.3% compared to prior year period and 0.9% on a constant currency basis Kevin Kenny, an experienced spine executive, joins as Global Spine President FDA approval of next generation Bone Growth Therapy patient monitoring app STIM onTrack 2.1Fiscal Year 2019 Highlights
Net sales of $460.0 million, an increase of 1.5% compared to prior year and 2.6% on a constant currency basis M6-C artificial disc achieves $4.1 million in sales in the US Successful transition to Jon Serbousek as... More